Does the company plan to provide any forwardâlooking statements or updates on pipeline progress during the event?
Based on the press release you provided, JourneyâŻMedicalâs announcement about ringing the Nasdaq closing bell focuses on two specific celebratory items:
- The companyâs 4âyear anniversary as a Nasdaqâlisted public company, and
- The commercial launch of Emrosi⢠(40âŻmg Minocycline Hydrochloride ModifiedâRelease Capsules) for rosacea.
The release does not mention any agenda items beyond those two points. In particular, there is no language indicating that management will issue forwardâlooking statements, provide an earnings outlook, or give updates on other pipeline programs during the bellâringing ceremony.
What this means for your question
Forwardâlooking statements: The notice does not state that the event will include any forwardâlooking statements. While many Nasdaq bellâringing events do include brief remarks that may contain forwardâlooking information, the only content disclosed in this release is the anniversary celebration and the Emrosi launch.
Pipeline progress updates: The release does not reference any pipeline candidates other than Emrosi (which is already commercialâstage). No updates on preâclinical or other clinical programs are mentioned.
In short: The press release does not indicate that JourneyâŻMedical plans to provide forwardâlooking statements or pipeline progress updates during the AugustâŻ11,âŻ2025 Nasdaq closingâbell ceremony. If such remarks are intended, they have not been disclosed in the information you provided.